Gaojie Cao

Mr. Gaojie Cao

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2025 in Viruses
Verified
Journal Article
Open access
PDF file
GCGaojie Cao
Gaojie Cao
CXChenhui Xu
Chenhui Xu
LWLinxi Wang
Linxi Wang
KCKeikei Chai
Keikei Chai
BWBeibei Wu
Beibei Wu
The continuous evolution of SARS-CoV-2 and its variants poses persistent challenges to global public health. As a sublineage of the XDV.1 variant, NB.1.8.1 has rapidly emerged as a dominant strain worldwide, triggering a new wave of infections. Representing a product of viral adaptation, this variant has acquired several critical amino acid mutations—including A435S and T478I—which enhance its transmissibility and immune evasion capabilities compared to the ancestral XDV.1 lineage. This review systematically summarizes the genomic characteristics, epidemiological features, and immune escape potential of NB.1.8.1. It emphasizes that sustained genomic surveillance and serological assessments are crucial for informing public health response strategies, guiding vaccine development, and optimizing containment measures.

4 October 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
KCKeke Chai
Keke Chai
CXChenhui Xu
Chenhui Xu
GCGaojie Cao
Gaojie Cao
LWLinxi Wang
Linxi Wang
YCYuying Chen
Yuying Chen
BWBeibei Wu
Beibei Wu
Antimicrobial resistance (AMR) is a complex One Health problem involving people, non-human species, and the environment. This review examines the distribution and transmission of multidrug-resistant (MDR) bacteria and antibiotic resistance genes (ARGs) across these domains. One Health has broken the long-standing isolation of MDR research by establishing a unified cross-disciplinary analytical framework, supporting interdisciplinary MDR studies, and systematically mapping the complete transmission chains and pathways of MDR determinants (including drug-resistant pathogens and resistance genes) at the human–animal–environment interface. This holistic perspective has become an indispensable guiding principle for addressing complex global health challenges.

19 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GCGaojie Cao
Gaojie Cao
CXChenhui Xu
Chenhui Xu
LWLinxi Wang
Linxi Wang
KCKeikei Chai
Keikei Chai
BWBeibei Wu
Beibei Wu
The continuous evolution of SARS-CoV-2 and its variants poses persistent challenges to global public health. As a sublineage of the XDV.1 variant, NB.1.8.1 has rapidly emerged as a dominant strain worldwide, triggering a new wave of infections. Representing a product of viral adaptation, this variant has acquired several critical amino acid mutations—including A435S and T478I—which enhance its transmissibility and immune evasion capabilities compared to the ancestral XDV.1 lineage. This review systematically summarizes the genomic characteristics, epidemiological features, and immune escape potential of NB.1.8.1. It emphasizes that sustained genomic surveillance and serological assessments are crucial for informing public health response strategies, guiding vaccine development, and optimizing containment measures.